VR
Venkateswara Rao Yarrabathina
About Venkateswara Rao Yarrabathina
Data last updated:
Venkateswara Rao Yarrabathina is an Additional Director at Hepa Pharma Private Limited (since 2021). The company operates in Pharma. Hepa Pharma Private Limited reported revenue of ₹19.94 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hepa Pharma Private Limited U24100TG2020PTC142664 | Additional Director | 04 Sep 2021 | 2020 | ₹19.94 Cr (FY 2024) | Active |
Board colleagues of Venkateswara Rao Yarrabathina
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sudheer Kumar Darapureddi | 10733121 | Hepa Pharma Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkateswara Rao Yarrabathina
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkateswara Rao Yarrabathina
Venkateswara Rao Yarrabathina currently holds 1 directorship: Hepa Pharma Private Limited (Additional Director, since 04 Sep 2021, revenue ₹19.94 Cr (FY 2024)).
Venkateswara Rao Yarrabathina was first appointed on 04 Sep 2021 as Additional Director at Hepa Pharma Private Limited.
The current boards of Venkateswara Rao Yarrabathina's companies include Sudheer Kumar Darapureddi (Hepa Pharma Private Limited).